Sponsors

Tumour HER2 status assay

  •  

Ipsogen has launched MapQuant Dx HER2 test. Developed on the MapQuant Dx microarray diagnostic platform, MapQuant Dx HER2 measures a set of HER2-amplified genes that correlate with HER2 protein expression. This new HER2 test provides reliable, intelligible and decisive information for pathologists, oncologists and patients.

MapQuant Dx HER2 is the second test to be developed on the MapQuant Dx platform, after the Genomic Grade launched by Ipsogen last year. As a result of the company’s experience in molecular diagnostics and to numerous research collaborations, it aims to continue to deliver innovative tests at an accelerated pace.
www.ipsogen.com

Other News

Study confirms new technology extends ESR test window

News

Sep 21, 2026

MHRA and Malaysia strengthen partnership on healthcare innovation and research

News

Sep 21, 2026

Roche opens new Innovation Centre Boston

News

Sep 21, 2026

Fuse Diagnostics raises £1 million to scale rapid POC molecular testing platform

News

Sep 18, 2026

International project targets faster sepsis pathogen identification

News

Sep 18, 2026

Improving specimen identification and reducing costs

News

Sep 17, 2026

Protein data help unlock diagnoses for rare conditions

News

Sep 15, 2026

£162 million boost for UK life sciences research

News

Sep 15, 2026

Commonly used cancer drugs boost MRSA antibiotics

News

Sep 15, 2026

Latest Issues

Epredia

Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...

Learn more »

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026

Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026